- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.28: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: N.122, T.124, V.127
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain A: E.132, N.165
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain A: G.232, N.234
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: N.603, T.604
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.616
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: N.709, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: N.122, T.124, V.127
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: E.132, N.165
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: G.232, N.234
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: N.603, T.604
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.616
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.45: 5 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
- Ligands: NAG.46
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Ligands: NAG.45
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.122, T.124, V.127
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: E.132, N.165
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: G.232, N.234
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain B: K.558
- Chain C: N.280, E.281, N.282
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.603, T.604
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain C: N.616
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain D: K.321, N.334
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, R. et al., Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2. Cell Res. (2021)
- Release Date
- 2021-03-31
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, R. et al., Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2. Cell Res. (2021)
- Release Date
- 2021-03-31
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D